BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34718649)

  • 1. Management of Childhood-onset Craniopharyngioma in Italy: A Multicenter, 7-Year Follow-up Study of 145 Patients.
    Zucchini S; Di Iorgi N; Pozzobon G; Pedicelli S; Parpagnoli M; Driul D; Matarazzo P; Baronio F; Crocco M; Iudica G; Partenope C; Nardini B; Ubertini G; Menardi R; Guzzetti C; Iughetti L; Aversa T; Di Mase R; Cassio A;
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1020-e1031. PubMed ID: 34718649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
    Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
    Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
    Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
    J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
    Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
    Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
    Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.
    Caldarelli M; Massimi L; Tamburrini G; Cappa M; Di Rocco C
    Childs Nerv Syst; 2005 Aug; 21(8-9):747-57. PubMed ID: 15995885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
    Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric craniopharyngioma: a 20-year study on epidemiological features, clinical presentation, and survival outcomes in a tertiary care center from LMIC.
    Memon F; Humayun KN; Riaz Q; Arif M; Huda NU; Laghari AA; Hilal K; Mushtaq N
    Childs Nerv Syst; 2024 Feb; 40(2):427-434. PubMed ID: 37837454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma.
    Mende KC; Kellner T; Petersenn S; Honegger J; Evangelista-Zamora R; Droste M; Stalla G; Deutschbein T; Wang Y; Moskopp D; Knappe U; Schilbach K; Flitsch J
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31589293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
    Pascual JM; Prieto R; Barrios L
    J Neurosurg; 2018 Oct; 131(3):949-963. PubMed ID: 30497204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Craniopharyngiomas.
    Alvarez M
    J Neurosci Nurs; 2006 Oct; 38(5):362-8. PubMed ID: 17069265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain.
    Iglesias P; Nocete I; Moure Rodríguez MD; Venegas-Moreno E; Ares J; Biagetti B; Rodríguez Berrocal V; Guerrero-Pérez F; Vicente A; Villar-Taibo R; Cordido F; Paja M; Glerean M; González Rivera N; Dios Fuentes E; Blanco C; Alvaréz-Escolá C; Martín T; Webb SM; Bernabéu I; Villabona C; Soto-Moreno A; Gaztambide S; Díez JJ
    Neuroendocrinology; 2021; 111(10):925-936. PubMed ID: 33040060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very long-term sequelae of craniopharyngioma.
    Wijnen M; van den Heuvel-Eibrink MM; Janssen JAMJL; Catsman-Berrevoets CE; Michiels EMC; van Veelen-Vincent MC; Dallenga AHG; van den Berge JH; van Rij CM; van der Lely AJ; Neggers SJCMM
    Eur J Endocrinol; 2017 Jun; 176(6):755-767. PubMed ID: 28325825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.
    Heinks K; Boekhoff S; Hoffmann A; Warmuth-Metz M; Eveslage M; Peng J; Calaminus G; Müller HL
    Endocrine; 2018 Feb; 59(2):364-372. PubMed ID: 29230635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniopharyngioma: endocrine sequelae of treatment.
    Sklar CA
    Pediatr Neurosurg; 1994; 21 Suppl 1():120-3. PubMed ID: 7841071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation.
    Gucev ZS; Danilovski D; Tasic V; Ugrinovski J; Nastova V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N; Kirovski I
    World J Pediatr; 2011 Feb; 7(1):74-8. PubMed ID: 21191780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.
    Klose M; Jonsson B; Abs R; Popovic V; Koltowska-Häggström M; Saller B; Feldt-Rasmussen U; Kourides I
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S75-83. PubMed ID: 19684053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.
    Müller HL; Gebhardt U; Schröder S; Pohl F; Kortmann RD; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Calaminus G; Kolb R; Wiegand C; Sörensen N;
    Horm Res Paediatr; 2010; 73(3):175-80. PubMed ID: 20197669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
    Miao Y; Fan K; Peng X; Li S; Chen J; Bai RN; Wei Y; Deng Y; Zhao C; Wu Q; Ge M; Gong J; Wu D
    Front Endocrinol (Lausanne); 2023; 14():1241145. PubMed ID: 38027203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.